I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Garcia, Yanelda
19
results:
Search for persons
X
Format
Online (19)
Mediatypes
Articles (Online) (9)
OpenAccess-fulltext (10)
Languages
english (16)
spanish (3)
Sorted by: Relevance
Sorted by: Year
?
1
Treatment of COVID‐19 patients with the anti‐CD6 antibody i..:
Caballero, Armando
;
Filgueira, Lázaro M
;
Betancourt, Julio
...
Clinical & Translational Immunology. 9 (2020) 11 - p. , 2020
Link:
https://doi.org/10.1002/..
?
2
CIGB-300, a synthetic peptide-based drug that targets the C..:
Perea, Silvio E.
;
Baladron, Idania
;
Garcia, Yanelda
...
Molecular and Cellular Biochemistry. 356 (2011) 1-2 - p. 45-50 , 2011
Link:
https://doi.org/10.1007/..
?
3
Open-label phase I/II clinical trial of SARS-CoV-2 receptor..:
Puga-Gómez, Rinaldo
;
Ricardo-Delgado, Yariset
;
Rojas-Iriarte, Chaumey
...
International Journal of Infectious Diseases. 126 (2023) - p. 164-173 , 2023
Link:
https://doi.org/10.1016/..
?
4
Safety and immunogenicity of anti-SARS-CoV-2 heterologous s..:
Toledo-Romani, María Eugenia
;
García-Carmenate, Mayra
;
Verdecia-Sánchez, Leslyhana
...
Med. 3 (2022) 11 - p. 760-773.e5 , 2022
Link:
https://doi.org/10.1016/..
?
5
Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERA..:
Eugenia-Toledo-Romaní, María
;
Verdecia-Sánchez, Leslyhana
;
Rodríguez-González, Meiby
...
Vaccine. 40 (2022) 31 - p. 4220-4230 , 2022
Link:
https://doi.org/10.1016/..
?
6
Pharmacokinetic and pharmacodynamic characterization of a n..:
for the CIGB-128-A Study Group
;
García-García, Idrian
;
Hernández-González, Ignacio
...
BMC Pharmacology and Toxicology. 17 (2016) 1 - p. , 2016
Link:
https://doi.org/10.1186/..
?
7
Pharmacokinetic and pharmacodynamic characterization of a n..:
García-Vega, Yanelda
;
García-García, Idrian
;
Collazo-Caballero, Sonia E
...
BMC Pharmacology and Toxicology. 13 (2012) 1 - p. , 2012
Link:
https://doi.org/10.1186/..
?
8
Treatment of advanced, recurrent, resistant to previous tre..:
Anasagasti-Angulo, Lorenzo
;
Garcia-Vega, Yanelda
;
Barcelona-Perez, Silvia
..
BMC Cancer. 9 (2009) 1 - p. , 2009
Link:
https://doi.org/10.1186/..
?
9
Bioequivalence of two recombinant granulocyte colony-stimul..:
Hernández-Bernal, Francisco
;
García-García, Idrian
;
González-Delgado, Carlos A.
...
Biopharmaceutics & Drug Disposition. 26 (2005) 4 - p. 151-159 , 2005
Link:
https://doi.org/10.1002/..
?
10
Treatment of COVID‐19 patients with the anti‐CD6 antibody i..:
Caballero, Armando
;
Filgueira, Lázaro M
;
Betancourt, Julio
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688906/. , 2020
Link:
http://www.ncbi.nlm.nih...
?
11
CIGB-300, a synthetic peptide-based drug that targets the C..:
Perea, Silvio E
;
Baladron, Idania
;
Garcia, Yanelda
...
info:eu-repo/semantics/altIdentifier/url/https://link.springer.com/article/10.1007/s11010-011-0950-y. ,
Link:
http://hdl.handle.net/11..
?
12
Open-label phase I/II clinical trial of SARS-CoV-2 receptor..:
Rinaldo Puga-Gómez
;
Yariset Ricardo-Delgado
;
Chaumey Rojas-Iriarte
...
http://www.sciencedirect.com/science/article/pii/S1201971222006014. , 2023
Link:
https://doi.org/10.1016/..
?
13
Respuesta clínica del tratamiento con HerberFERON( en pacie..:
Irene Rojas Rondón
;
Lázaro Vigoa Aranguren
;
Yanelda Garcìa Vega
..
http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21762021000100013&tlng=es. , 2021
Link:
https://doaj.org/article..
?
14
Seguridad del HeberFERON( en pacientes con carcinoma basal ..:
Irene Rojas Rondón
;
Lázaro Vigoa Aranguren
;
Yanelda García Vega
..
http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21762021000100011&tlng=es. , 2021
Link:
https://doaj.org/article..
?
15
Pharmacokinetic and pharmacodynamic characterization of a n..:
García-García, Idrian
;
Hernández-González, Ignacio
;
Díaz-Machado, Alina
...
http://www.biomedcentral.com/2050-6511/17/58. , 2016
Link:
http://www.biomedcentral..
1-15